RNTX
Rein Therapeutics Inc
NASDAQ: RNTX · HEALTHCARE · BIOTECHNOLOGY
$1.36
+6.27% today
Updated 2026-04-30
Market cap
$40.66M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.96
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
Rein Therapeutics Inc (RNTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-139.90%
ROA
-31.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-21157.00 | — | — | — |
| 2021 | $0.00 | $-26164.00 | — | — | — |
| 2022 | $0.00 | $-27329.00 | — | — | — |
| 2023 | $0.00 | $-15732.00 | — | — | — |
| 2024 | $0.00 | $-62.88M | — | — | — |
| 2025 | $0.00 | $-49.87M | — | — | — |